Stay updated with breaking news from Calyxt Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting • Execution of strategic...
The rising incidence of cancer, especially hematological malignancies like leukemia and lymphoma, has been a driving force behind the growth of the CAR-T...
In the peer reviewed publication, the International Journal of Plant Biology, Cibus provides two case studies of improving oleic oil content and developing pod shatter reduction in Brassica napus ...
UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION Introductory Note On May 31, 2023, Cibus, Inc. completed its business combination in...
Cibus Announces Election of New Board Member, Deepening Strategic Leadership and Experience SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a global leader in Gene Editing in agriculture and